vs
Side-by-side financial comparison of PAVmed Inc. (PAVM) and Hyperliquid Strategies Inc (PURR). Click either name above to swap in a different company.
PAVmed Inc. is the larger business by last-quarter revenue ($996.0K vs $500.0K, roughly 2.0× Hyperliquid Strategies Inc). PAVmed Inc. runs the higher net margin — 6465.8% vs -60892.6%, a 67358.4% gap on every dollar of revenue.
PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.
PAVM vs PURR — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $996.0K | $500.0K |
| Net Profit | $64.4M | $-304.5M |
| Gross Margin | -38.7% | — |
| Operating Margin | -1162.4% | -57509.2% |
| Net Margin | 6465.8% | -60892.6% |
| Revenue YoY | 25.9% | — |
| Net Profit YoY | 464.4% | — |
| EPS (diluted) | $1.44 | $-7.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $500.0K | ||
| Q3 24 | $996.0K | — | ||
| Q2 24 | $979.0K | — | ||
| Q1 24 | $1.0M | — | ||
| Q4 23 | $1.0M | — | ||
| Q3 23 | $791.0K | — | ||
| Q2 23 | $166.0K | — | ||
| Q1 23 | $446.0K | — |
| Q4 25 | — | $-304.5M | ||
| Q3 24 | $64.4M | — | ||
| Q2 24 | $-10.8M | — | ||
| Q1 24 | $-15.2M | — | ||
| Q4 23 | $-14.0M | — | ||
| Q3 23 | $-17.7M | — | ||
| Q2 23 | $-14.5M | — | ||
| Q1 23 | $-17.9M | — |
| Q4 25 | — | — | ||
| Q3 24 | -38.7% | — | ||
| Q2 24 | -70.2% | — | ||
| Q1 24 | -72.7% | — | ||
| Q4 23 | -53.5% | — | ||
| Q3 23 | -124.9% | — | ||
| Q2 23 | -915.1% | — | ||
| Q1 23 | -201.8% | — |
| Q4 25 | — | -57509.2% | ||
| Q3 24 | -1162.4% | — | ||
| Q2 24 | -1397.8% | — | ||
| Q1 24 | -1389.7% | — | ||
| Q4 23 | -1561.7% | — | ||
| Q3 23 | -1963.1% | — | ||
| Q2 23 | -9930.1% | — | ||
| Q1 23 | -4574.2% | — |
| Q4 25 | — | -60892.6% | ||
| Q3 24 | 6465.8% | — | ||
| Q2 24 | -1105.9% | — | ||
| Q1 24 | -1506.1% | — | ||
| Q4 23 | -1338.0% | — | ||
| Q3 23 | -2234.0% | — | ||
| Q2 23 | -8757.2% | — | ||
| Q1 23 | -4020.4% | — |
| Q4 25 | — | $-7.43 | ||
| Q3 24 | $1.44 | — | ||
| Q2 24 | $-1.19 | — | ||
| Q1 24 | $-2.62 | — | ||
| Q4 23 | $-1.90 | — | ||
| Q3 23 | $-2.38 | — | ||
| Q2 23 | $-2.10 | — | ||
| Q1 23 | $-2.78 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $765.0K | $281.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-4.9M | $589.8M |
| Total Assets | $30.6M | $616.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $281.9M | ||
| Q3 24 | $765.0K | — | ||
| Q2 24 | $25.5M | — | ||
| Q1 24 | $25.5M | — | ||
| Q4 23 | $19.6M | — | ||
| Q3 23 | $26.4M | — | ||
| Q2 23 | $37.2M | — | ||
| Q1 23 | $49.3M | — |
| Q4 25 | — | $589.8M | ||
| Q3 24 | $-4.9M | — | ||
| Q2 24 | $-73.9M | — | ||
| Q1 24 | $-68.8M | — | ||
| Q4 23 | $-53.8M | — | ||
| Q3 23 | $-43.3M | — | ||
| Q2 23 | $-31.5M | — | ||
| Q1 23 | $-22.1M | — |
| Q4 25 | — | $616.6M | ||
| Q3 24 | $30.6M | — | ||
| Q2 24 | $39.4M | — | ||
| Q1 24 | $37.3M | — | ||
| Q4 23 | $33.1M | — | ||
| Q3 23 | $42.0M | — | ||
| Q2 23 | $53.7M | — | ||
| Q1 23 | $65.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.9M | — |
| Free Cash FlowOCF − Capex | $-8.9M | — |
| FCF MarginFCF / Revenue | -892.5% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | -0.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 24 | $-8.9M | — | ||
| Q2 24 | $-11.7M | — | ||
| Q1 24 | $-13.1M | — | ||
| Q4 23 | $-11.9M | — | ||
| Q3 23 | $-11.1M | — | ||
| Q2 23 | $-12.7M | — | ||
| Q1 23 | $-16.4M | — |
| Q4 25 | — | — | ||
| Q3 24 | $-8.9M | — | ||
| Q2 24 | $-11.7M | — | ||
| Q1 24 | $-13.2M | — | ||
| Q4 23 | $-12.1M | — | ||
| Q3 23 | $-11.1M | — | ||
| Q2 23 | $-12.7M | — | ||
| Q1 23 | $-16.4M | — |
| Q4 25 | — | — | ||
| Q3 24 | -892.5% | — | ||
| Q2 24 | -1190.9% | — | ||
| Q1 24 | -1302.1% | — | ||
| Q4 23 | -1149.4% | — | ||
| Q3 23 | -1404.2% | — | ||
| Q2 23 | -7666.3% | — | ||
| Q1 23 | -3674.4% | — |
| Q4 25 | — | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 4.2% | — | ||
| Q4 23 | 17.4% | — | ||
| Q3 23 | 2.3% | — | ||
| Q2 23 | 9.0% | — | ||
| Q1 23 | 5.8% | — |
| Q4 25 | — | — | ||
| Q3 24 | -0.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
